Global Bipolar Disorder Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 146158
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 128
  • list Pharmaceuticals and Healthcare

Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.

Scope of the Report:

This report studies the Bipolar Disorder Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bipolar Disorder Therapeutics market by product type and applications/end industries.

The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.

The global Bipolar Disorder Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bipolar Disorder Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

AstraZeneca

Bristol-Myers Squibb

Eli Lilly

Astellas Pharma

Allergan

Johnson & Johnson

GlaxoSmithKline

AbbVie

Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Mood Stabilizers

Antipsychotic Drugs

Antidepressant Drugs

Other Drugs

Market Segment by Applications, can be divided into

Selective Serotonin Reuptake Inhibitors

Serotonin-norepinephrine Reuptake Inhibitors

Tricyclic Antidepressants

Monoamine Oxidase Inhibitors

Benzodiazepines

Beta Blockers

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Bipolar Disorder Therapeutics Market Overview

1.1 Product Overview and Scope of Bipolar Disorder Therapeutics

1.2 Classification of Bipolar Disorder Therapeutics by Types

1.2.1 Global Bipolar Disorder Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Bipolar Disorder Therapeutics Revenue Market Share by Types in 2017

1.2.3 Mood Stabilizers

1.2.4 Antipsychotic Drugs

1.2.5 Antidepressant Drugs

1.2.6 Other Drugs

1.3 Global Bipolar Disorder Therapeutics Market by Application

1.3.1 Global Bipolar Disorder Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Selective Serotonin Reuptake Inhibitors

1.3.3 Serotonin-norepinephrine Reuptake Inhibitors

1.3.4 Tricyclic Antidepressants

1.3.5 Monoamine Oxidase Inhibitors

1.3.6 Benzodiazepines

1.3.7 Beta Blockers

1.3.8 Others

1.4 Global Bipolar Disorder Therapeutics Market by Regions

1.4.1 Global Bipolar Disorder Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Bipolar Disorder Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Bipolar Disorder Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bipolar Disorder Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Bipolar Disorder Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bipolar Disorder Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Bipolar Disorder Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 AstraZeneca

2.1.1 Business Overview

2.1.2 Bipolar Disorder Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AstraZeneca Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bristol-Myers Squibb

2.2.1 Business Overview

2.2.2 Bipolar Disorder Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Bipolar Disorder Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Astellas Pharma

2.4.1 Business Overview

2.4.2 Bipolar Disorder Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Astellas Pharma Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Allergan

2.5.1 Business Overview

2.5.2 Bipolar Disorder Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Allergan Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson

2.6.1 Business Overview

2.6.2 Bipolar Disorder Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.7 GlaxoSmithKline

2.7.1 Business Overview

2.7.2 Bipolar Disorder Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GlaxoSmithKline Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.8 AbbVie

2.8.1 Business Overview

2.8.2 Bipolar Disorder Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 AbbVie Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.9 Pfizer

2.9.1 Business Overview

2.9.2 Bipolar Disorder Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Pfizer Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.10 Novartis

2.10.1 Business Overview

2.10.2 Bipolar Disorder Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Novartis Bipolar Disorder Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Bipolar Disorder Therapeutics Market Competition, by Players

3.1 Global Bipolar Disorder Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Bipolar Disorder Therapeutics Players Market Share

3.2.2 Top 10 Bipolar Disorder Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Bipolar Disorder Therapeutics Market Size by Regions

4.1 Global Bipolar Disorder Therapeutics Revenue and Market Share by Regions

4.2 North America Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Bipolar Disorder Therapeutics Revenue by Countries

5.1 North America Bipolar Disorder Therapeutics Revenue by Countries (2013-2018)

5.2 USA Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Bipolar Disorder Therapeutics Revenue by Countries

6.1 Europe Bipolar Disorder Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Bipolar Disorder Therapeutics Revenue by Countries

7.1 Asia-Pacific Bipolar Disorder Therapeutics Revenue by Countries (2013-2018)

7.2 China Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Bipolar Disorder Therapeutics Revenue by Countries

8.1 South America Bipolar Disorder Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Bipolar Disorder Therapeutics by Countries

9.1 Middle East and Africa Bipolar Disorder Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Bipolar Disorder Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Bipolar Disorder Therapeutics Market Segment by Type

10.1 Global Bipolar Disorder Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Bipolar Disorder Therapeutics Market Forecast by Type (2018-2023)

10.3 Mood Stabilizers Revenue Growth Rate (2013-2023)

10.4 Antipsychotic Drugs Revenue Growth Rate (2013-2023)

10.5 Antidepressant Drugs Revenue Growth Rate (2013-2023)

10.6 Other Drugs Revenue Growth Rate (2013-2023)

11 Global Bipolar Disorder Therapeutics Market Segment by Application

11.1 Global Bipolar Disorder Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Bipolar Disorder Therapeutics Market Forecast by Application (2018-2023)

11.3 Selective Serotonin Reuptake Inhibitors Revenue Growth (2013-2018)

11.4 Serotonin-norepinephrine Reuptake Inhibitors Revenue Growth (2013-2018)

11.5 Tricyclic Antidepressants Revenue Growth (2013-2018)

11.6 Monoamine Oxidase Inhibitors Revenue Growth (2013-2018)

11.7 Benzodiazepines Revenue Growth (2013-2018)

11.8 Beta Blockers Revenue Growth (2013-2018)

11.9 Others Revenue Growth (2013-2018)

12 Global Bipolar Disorder Therapeutics Market Size Forecast (2018-2023)

12.1 Global Bipolar Disorder Therapeutics Market Size Forecast (2018-2023)

12.2 Global Bipolar Disorder Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Bipolar Disorder Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Bipolar Disorder Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Bipolar Disorder Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Bipolar Disorder Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Bipolar Disorder Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Bipolar Disorder Therapeutics Picture

Table Product Specifications of Bipolar Disorder Therapeutics

Table Global Bipolar Disorder Therapeutics and Revenue (Million U

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery